Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06630169
PHASE2

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Sponsor: Aurion Biotech

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the safety and efficacy of cryopreserved AURN001 in patients with corneal edema secondary to endothelial dysfunction.

Official title: APANECA: A Prospective, Parallel-arm, Multi-Surgeon Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (2024-E002-C)

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2024-09-16

Completion Date

2025-10

Last Updated

2025-01-28

Healthy Volunteers

No

Conditions

Interventions

COMBINATION_PRODUCT

Cryopreserved AURN001

Corneal Endothelial Cells and Y27632

Locations (1)

Aurion Biotech site

San Salvador, El Salvador